Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TRIAMCINOLONE Cause Product quality issue? 152 Reports in FDA Database

Visibly Younger Skin in Weeks

Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.

Discover Synevra

According to the FDA Adverse Event Reporting System (FAERS), 152 reports of Product quality issue have been filed in association with TRIAMCINOLONE. This represents 2.3% of all adverse event reports for TRIAMCINOLONE.

152
Reports of Product quality issue with TRIAMCINOLONE
2.3%
of all TRIAMCINOLONE reports
129
Deaths
73
Hospitalizations

How Dangerous Is Product quality issue From TRIAMCINOLONE?

Of the 152 reports, 129 (84.9%) resulted in death, 73 (48.0%) required hospitalization, and 65 (42.8%) were considered life-threatening.

Is Product quality issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TRIAMCINOLONE. However, 152 reports have been filed with the FAERS database.

What Other Side Effects Does TRIAMCINOLONE Cause?

Drug ineffective (3,035) Psoriasis (1,131) Off label use (901) Product use in unapproved indication (724) Condition aggravated (625) Therapeutic product effect incomplete (624) Treatment failure (612) Drug intolerance (527) Nausea (525) Pruritus (485)

What Other Drugs Cause Product quality issue?

ETONOGESTREL (4,651) ALBUTEROL (4,466) TIOTROPIUM (3,821) MOMETASONE FUROATE (3,406) LIDOCAINE (3,126) FLUTICASONE\SALMETEROL (2,986) FORMOTEROL\MOMETASONE FUROATE (2,458) FENTANYL (2,450) NICOTINE (1,987) EXENATIDE (1,839)

Which TRIAMCINOLONE Alternatives Have Lower Product quality issue Risk?

TRIAMCINOLONE vs TRIAMCINOLONE ACETONIDE TRIAMCINOLONE vs TRIAMCINOLONE HEXACETONIDE TRIAMCINOLONE vs TRIAMTERENE TRIAMCINOLONE vs TRIATEC TRIAMCINOLONE vs TRIAZOLAM

Related Pages

TRIAMCINOLONE Full Profile All Product quality issue Reports All Drugs Causing Product quality issue TRIAMCINOLONE Demographics